To include your compound in the COVID-19 Resource Center, submit it here.

Disease models

TECHNOLOGY: 3-D models

Patient-derived metastatic colorectal, esophageal and biliary cancer organoids could help predict individual patient responses to treatment. The organoids are generated by culturing enzyme-dissociated cells from patient metastatic tumor samples and suspending

Read the full 334 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE